HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D Owens Selected Research

Type 2 Diabetes Mellitus (MODY)

4/2015The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice?
6/2014Residual dysglycemia when at target HbA(1c) of 7% (53mmol/mol) in persons with type 2 diabetes.
12/2013Basal insulin analogs: from pathophysiology to therapy. What we see, know, and try to comprehend?
4/2013Insulin and atherosclerosis: how are they related?
2/2010Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study.
5/2006Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein.
4/2004Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes.
1/2001The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
10/2000Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet.
8/2000Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D Owens Research Topics

Disease

12Type 2 Diabetes Mellitus (MODY)
04/2015 - 02/2000
5Atherosclerosis
04/2013 - 10/2000
4Insulin Resistance
06/2009 - 02/2000
2Neoplasms (Cancer)
02/2022 - 12/2013
2Tonsillitis
06/2017 - 11/2008
1Obesity
02/2022
1Conductive Hearing Loss
03/2019
1Confusion (Bewilderment)
01/2018
1Epistaxis (Nosebleed)
12/2017
1Peritonsillar Abscess
06/2017
1Overnutrition
01/2017
1Dyslipidemias (Dyslipidemia)
01/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2014
1Primary Hyperparathyroidism
07/2014
1Inflammation (Inflammations)
04/2013
1Weight Gain
02/2010
1Pituitary Diseases (Disease, Anterior Pituitary)
04/2009
1Inappropriate ADH Syndrome (SIADH)
04/2009
1Brain Neoplasms (Brain Tumor)
04/2009
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2009
1Anthrax
08/2005
1Macular Degeneration (Age-Related Maculopathy)
12/2003
1Diabetic Retinopathy (Retinopathy, Diabetic)
12/2003
1Cardiovascular Diseases (Cardiovascular Disease)
10/2003
1Sickle Cell Anemia (Hemoglobin S Disease)
05/2003
1Retinal Vein Occlusion
11/2001
1Hypoglycemia (Reactive Hypoglycemia)
01/2001
1Poisoning
01/2001
1Thromboembolism
12/2000
1Type 1 von Willebrand Disease
12/2000
1Venous Thromboembolism
12/2000
1Myocardial Infarction
08/2000

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
01/2018 - 02/2000
7Lipoproteins (Lipoprotein)IBA
01/2017 - 08/2000
4Insulin (Novolin)FDA Link
12/2014 - 02/2010
3Insulin Glargine (Lantus)FDA Link
12/2014 - 02/2010
3microsomal triglyceride transfer proteinIBA
05/2006 - 02/2002
2insulin degludecIBA
12/2014 - 12/2013
2ChylomicronsIBA
05/2006 - 02/2002
2CholesterolIBA
05/2006 - 10/2003
2Prothrombin (Factor II)IBA
11/2001 - 12/2000
2Oleic Acid (Oleate)IBA
10/2000 - 02/2000
2ApolipoproteinsIBA
08/2000 - 02/2000
1RadonIBA
02/2022
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
01/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2014
1Insulin Detemir (Levemir)FDA Link
12/2013
1LipidsIBA
04/2013
1Metformin (Glucophage)FDA LinkGeneric
02/2010
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2009
1Rosuvastatin Calcium (Crestor)FDA Link
06/2009
1Vasopressins (Vasopressin)IBA
04/2009
1SodiumIBA
04/2009
1SaltsIBA
04/2009
1Messenger RNA (mRNA)IBA
05/2006
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
05/2006
1AerosolsIBA
08/2005
1LDL CholesterolIBA
04/2004
1Fatty Acids (Saturated Fatty Acids)IBA
10/2003
1Combined Oral ContraceptivesIBA
05/2003
1Progestins (Progestagens)IBA
05/2003
1ThrombinFDA Link
05/2003
1Biomarkers (Surrogate Marker)IBA
05/2003
1Factor VIII (Coagulation Factor VIII)IBA
11/2001
1HomocysteineIBA
11/2001
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
11/2001
1repaglinide (Prandin)FDA Link
01/2001
1ElementsIBA
01/2001
1Apolipoproteins B (ApoB)IBA
01/2001
1factor V LeidenIBA
12/2000
1von Willebrand FactorIBA
12/2000
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2000
1Linoleic Acid (Linoleate)IBA
10/2000
1Sunflower OilIBA
10/2000
1Olive OilIBA
10/2000
1Chylomicron RemnantsIBA
10/2000
1Triglycerides (Triacylglycerol)IBA
08/2000
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2000

Therapy/Procedure

2Tonsillectomy
06/2017 - 11/2008
2Therapeutics
04/2013 - 08/2000
1Ear Protective Devices (Earplug)
03/2019
1Cautery
12/2017
1Parathyroidectomy
07/2014
1Light Coagulation
12/2003
1Hormonal Contraception
05/2003
1Contraception (Birth Control)
05/2003
1Mediterranean Diet
02/2000